Skip to main content

News

Inaedis Selected for Merck Digital Sciences Studio Cohort
November 25, 20252 min

Inaedis Selected for Merck Digital Sciences Studio Cohort

PRESS RELEASE Princeton, NJ, Nov 19, 2024 – Inaedis is proud to announce its acceptance into the latest cohort of the Merck Digital Sciences Studio (MDS Studio), a digital accelerator…
ib6OX38yBHJGib6OX38yBHJG
Inaedis Wins Prestigious NSF SBIR Phase II Award to Revolutionize Biologic Drug Stability
September 9, 20254 min

Inaedis Wins Prestigious NSF SBIR Phase II Award to Revolutionize Biologic Drug Stability

PRINCETON, NEW JERSEY (June 17, 2025) – Inaedis, Inc. is thrilled to announce it has been awarded a highly competitive $1.25 million Phase II Small Business Innovation Research (SBIR) grant from…
ib6OX38yBHJGib6OX38yBHJG
Inaedis Awarded Competitive SBIR Phase I Contract from the U.S. Department of Defense
September 9, 20254 min

Inaedis Awarded Competitive SBIR Phase I Contract from the U.S. Department of Defense

DoD SBIR Program Provides Funding to Advance Thermostable Biologic and Vaccine Formulations PRINCETON, NEW JERSEY – September 8, 2025 – Inaedis Inc. has been awarded a Phase I Small Business Innovation…
ib6OX38yBHJGib6OX38yBHJG